FDA Inspection 1113974 - Avista Pharma Solutions, Inc. dba Cambrex - December 18, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Avista Pharma Solutions, Inc. dba Cambrex

Record Details

This FDA Inspection record concerns Avista Pharma Solutions, Inc. dba Cambrex, with an inspection on December 18, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Avista Pharma Solutions, Inc. dba Cambrex
Inspection Date: December 18, 2019
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 43a50e53-b23a-4132-b1c6-e57509860e23

Violation Codes2

21 CFR 211.22(d)21 CFR 211.67(a)

Full citation text and observation details available on the Dashboard.